Cognitive enhancement through supplementation is most effective when compounds are strategically combined based on complementary mechanisms of action and robust clinical evidence. Rather than relying on a single agent, a well-designed "stack" leverages synergistic effects—where compounds work through different pathways to produce cumulative improvements in memory, attention, processing speed, and executive function.
This guide presents an evidence-based framework for building a cognitive stack, organized by evidence tier and cost-effectiveness. The goal is to provide actionable recommendations grounded in human clinical research, not animal models or theoretical promise. Each recommendation includes the clinical evidence, optimal dosing protocols, and realistic timelines for results.
Cognitive enhancement stacks function best when layered by evidence quality and individual goals:
- Foundation Stack (Tier 4): Compounds with the strongest human clinical evidence and consistent, replicable effects across multiple independent research groups
- Enhancement Stack (Tier 3): Probable efficacy based on solid human studies with modest effect sizes or more limited replication
- Advanced Stack: Peptides and high-cost interventions for individuals seeking maximum investment or those with specific cognitive conditions
These compounds represent the evidence-based foundation of any cognitive enhancement protocol. Each has demonstrated clinically meaningful improvements in human randomized controlled trials with consistent replication.
Role: Energy substrate for ATP production in neural tissue; particularly effective for memory and processing speed.
Evidence: A meta-analysis of 16 randomized controlled trials (492 total participants) demonstrated that creatine supplementation improved memory by 0.31 standard mean deviations (95% CI: 0.18–0.44) and processing speed by 0.51 SMD (95% CI: 1.01–0.01) compared to placebo. Effects are most pronounced in older adults and individuals with vegetarian diets (lower baseline creatine stores).
Mechanism: Creatine serves as a phosphate buffer in the brain, enabling rapid ATP regeneration during sustained cognitive tasks. Effects are particularly notable in tasks demanding working memory and rapid information processing.
Dosing: 3–5g once daily (oral). No loading phase is necessary; steady-state benefits emerge within 2–4 weeks of consistent supplementation.
Timing: Morning with food and water. Consistent daily intake matters more than timing relative to cognitive tasks.
Cost: $8–$25 per month
Timeline to Effect: 2–4 weeks at therapeutic dose
This pairing represents one of the most reliable cognitive enhancements available, backed by multiple high-quality human trials.
Caffeine
Role: Adenosine receptor antagonist; increases arousal, attention, and processing speed.
Evidence: Meta-analyses confirm caffeine improves digit vigilance accuracy (SMD 0.20, 95% CI 0.02–0.38) and attention-switching accuracy (SMD 0.33, 95% CI 0.13–0.54) within 2 hours in healthy adults. Effects are consistent across cognitive domains, though magnitude varies by individual sensitivity and baseline caffeine consumption.
Dosing: 100–200mg once or twice daily. Start at 100mg to assess tolerance; divide into two doses if split dosing improves sustained attention throughout the day.
Cost: $3–$15 per month
L-Theanine
Role: Glutamate analog that increases alpha-wave brain activity (associated with relaxed focus); synergizes with caffeine to enhance attention without jitteriness.
Evidence: When combined with caffeine, L-theanine improved hit rate (p=0.02) and target-discriminability (p=0.047) in sleep-deprived adults, with reaction time improvements of 38.1 milliseconds greater than placebo (p=0.003). The combination is particularly effective in cognitively demanding situations or under sleep debt.
Dosing: 100–200mg once or twice daily. Pair timing with caffeine intake for synergistic effect.
Cost: $8–$25 per month
Combined Timing: Take together with or immediately after caffeine dosing. Morning dose for sustained attention; optional afternoon dose if additional focus is needed (avoid within 6 hours of bedtime due to residual caffeine).
Timeline to Effect: Immediate to 30 minutes; effects sustained for 4–6 hours
Role: Adaptogenic herb; improves memory consolidation, attention, and executive function while reducing cognitive fatigue.
Evidence: An 8-week randomized controlled trial (n=50) of adults with mild cognitive impairment demonstrated significant improvements across multiple memory domains: logical memory I (p=0.007), verbal paired associates I (p=0.042), faces I (p=0.020), and family pictures I (p=0.006) on the Wechsler Memory Scale III. Effects have been consistently replicated across independent research groups with sample sizes ranging from 43–130 participants.
Mechanism: Withanolides (active constituents) enhance dendritic growth and synaptic plasticity while reducing cortisol-induced cognitive decline. Particularly effective for attention and executive function.
Dosing: 300–600mg once daily or split into two 150–300mg doses. Standardized extracts containing 5% withanolides are most reliable.
Timing: Morning with food for optimal absorption. Consistent daily intake is essential; benefits typically emerge over 4–8 weeks.
Cost: $15–$45 per month
Timeline to Effect: 4–8 weeks at therapeutic dose
Role: Powerful antioxidant; protects cognitive function through reduced oxidative stress and improved cerebral blood flow.
Evidence: A 12-week randomized controlled trial (n=60 healthy professionals) demonstrated significant improvements in cognitive function, attention, and mental performance with 150mg daily Pycnogenol. Oxidative stress decreased by 30.4% versus +0.9% in placebo controls (p<0.05). Consistent across multiple human RCTs with effect sizes ranging from 7–30% improvements on standardized cognitive measures.
Mechanism: Proanthocyanidins (principal bioactive compounds) reduce neural oxidative stress, improve blood-brain barrier function, and enhance cerebral perfusion. Effects are synergistic with other antioxidants.
Dosing: 100–200mg once daily (oral). 150mg daily is the dose most consistently associated with cognitive benefits in the literature.
Timing: Morning with food. Fatty food enhances bioavailability.
Cost: $20–$55 per month
Timeline to Effect: 4–12 weeks for measurable improvements
These compounds demonstrate probable efficacy based on solid human research with modest effect sizes, smaller sample sizes, or more limited independent replication. They serve as valuable additions to the Foundation Stack for targeted cognitive enhancement.
Role: Structural component of neuronal membranes; supports synaptic plasticity and cerebral perfusion.
Evidence: A 24-month randomized controlled trial (n=90, 60 active, 30 placebo) demonstrated working memory improvements with 430mg DHA + 90mg EPA combined with carotenoids and vitamin E in cognitively healthy older adults (effect sizes 0.090–0.105, p significant). Benefits are most consistent in older adults and those with existing cognitive decline; effects are less pronounced in young, healthy populations.
Dosing: 1000–4000mg combined EPA+DHA daily, divided into one or two doses. Higher doses (2000–4000mg) are associated with stronger effects in literature but increase cost and gastrointestinal side effects.
Timing: With meals containing fat for enhanced absorption. Consistent daily intake matters more than specific timing.
Cost: $10–$60 per month (varies widely by product quality and EPA:DHA ratio)
Timeline to Effect: 8–12 weeks for measurable memory improvements
Role: Polyphenolic anti-inflammatory; crosses blood-brain barrier and reduces neuroinflammation.
Evidence: A meta-analysis of 9 randomized controlled trials (n=501) demonstrated that curcumin significantly improved global cognitive function versus placebo (SMD=0.82, 95% CI 0.19–1.45, p=0.010). Optimal dose was 0.8g daily over durations of at least 24 weeks. Most effective for working memory and processing speed in older adults.
Dosing: 500–1000mg twice daily (oral). Must be taken with black pepper extract (piperine) or fat to enhance bioavailability—curcumin alone has poor absorption.
Timing: With meals containing fat. Divide dosing across morning and evening for consistent blood levels.
Cost: $10–$55 per month
Timeline to Effect: 8–12 weeks for measurable effects; optimal benefit at 24+ weeks
Role: Gut-brain axis modulation; alters inflammatory signaling and neurotransmitter precursor availability.
Evidence: A meta-analysis of 12 randomized controlled trials (n=852) in Alzheimer's disease and mild cognitive impairment patients demonstrated that probiotics improved global cognitive function (SMD=0.67, 95% CI 0.32–1.02), delayed memory (SMD=0.67), attention (SMD=0.31), and visuospatial/constructional function (SMD=0.24). Effects are most pronounced in older adults with existing cognitive decline.
Dosing: 10–100 billion colony-forming units (CFU) daily. Multi-strain formulas (4+ different species) are more effective than single-strain products.
Timing: Once daily with or without food. Consistency matters more than timing; establish a routine and maintain daily supplementation.
Cost: $15–$80 per month (depending on strain quality and CFU count)
Timeline to Effect: 8–12 weeks for measurable cognitive improvement
Role: Circadian rhythm regulation; neuroprotective antioxidant properties enhance cognitive processing during sleep recovery.
Evidence: In type 2 diabetes patients (n=154, observational), 5mg melatonin daily for 12 weeks improved Montreal Cognitive Assessment scores versus placebo. Benefits are most consistent in populations with mild cognitive impairment, type 2 diabetes, or multiple sclerosis. However, one large feasibility trial showed no significant cognitive benefit versus placebo in a general population.
Dosing: 0.5–5mg once daily in the evening, 30–60 minutes before bedtime. Start at lower doses (0.5–1mg) and titrate upward if needed.
Timing: Evening only, taken 30–60 minutes before sleep. Do not use during daytime cognitive tasks.
Cost: $4–$20 per month
Timeline to Effect: 2–4 weeks for sleep quality improvements; cognitive effects may lag by 4–12 weeks
Role: Sirtuins activator; promotes cellular stress resistance and mitochondrial function in neural tissue.
Evidence: A meta-analysis of 3 randomized controlled trials (n=166) demonstrated that resveratrol improved delayed recognition versus placebo (SMD 0.39, 95% CI 0.08–0.70, p=0.01). Benefits are most pronounced in postmenopausal women and Alzheimer's disease patients; evidence is limited by small sample sizes and short study durations.
Dosing: 250–500mg once daily (oral).
Timing: Morning or midday with food containing fat.
Cost: $10–$45 per month
Timeline to Effect: 8–12 weeks for measurable effects
Role: Essential cofactor for synaptic plasticity; involved in NMDA receptor signaling and hippocampal long-term potentiation.
Evidence: In schoolchildren (n=36, randomized controlled trial), 5mg zinc daily for 3 months improved performance IQ on Picture Completion, Picture Arrangement, Block Design, and Object Assembly subtests (p=0.0001), though full-scale and verbal IQ did not improve significantly. Results in adults are mixed; effects are most consistent in populations with baseline zinc deficiency.
Dosing: 15–30mg elemental zinc once daily. Do not exceed 40mg daily chronically, as excessive zinc impairs copper absorption.
Timing: Morning with food.
Cost: $8–$25 per month
Timeline to Effect: 4–8 weeks, most pronounced in zinc-deficient populations
Role: Mitochondrial electron transport chain component; enhances ATP production in neural cells.
Evidence: Plasma CoQ10 levels were significantly associated with cognitive functioning and executive function in older adults (n=64, observational study, controlling for physical activity and nutritional status). Evidence is primarily observational; limited high-quality RCT data exists.
Dosing: 100–300mg once or twice daily. Ubiquinol form has superior bioavailability compared to ubiquinone.
Timing: With meals containing fat.
Cost: $20–$75 per month
Timeline to Effect: 8–12 weeks
Role: Hepatoprotective and neuroprotective antioxidant; reduces oxidative stress and neuroinflammation.
Evidence: Silymarin adjunctive therapy in Alzheimer's patients (n=33, randomized controlled trial) improved Mini-Mental State Examination scores by 2.98 points (p<0.001) and reduced serum malondialdehyde (oxidative stress marker) by 61% (p<0.001) over 12 weeks. Evidence remains limited by small sample sizes and lacks independent replication in larger populations.
Dosing: 420–600mg standardized silymarin extract (70–80% silymarin) three times daily.
Timing: With meals. Consistent daily intake is essential.
Cost: $8–$45 per month
Timeline to Effect: 8–12 weeks
Peptide-based interventions represent a higher-cost, research-intensive approach to cognitive enhancement. Evidence for these compounds is probable but more limited than Foundation Stack options.
Role: Neuropeptide complex; enhances neural growth factor activity and synaptic plasticity.
Evidence: In vascular dementia (meta-analysis of 6 randomized controlled trials, n=597): Mini-Mental State Examination improved by 1.10 points versus placebo (95% CI 0.37–1.82); Alzheimer's Disease Assessment Scale-cognitive improved by 4.01 points (95% CI 5.36–2.66). Evidence is limited by small sample sizes and inconsistent effect measurements.
Dosing: 5–30mL (215–1290mg peptide fraction) once daily for clinical courses; 3–5 times per week for off-label cognitive use (intramuscular or intravenous injection).
Timing: Daily during intensive treatment phases (2–4 week courses); maintenance dosing 3–5 times weekly.
Cost: $80–$400 per month
Availability: Prescription required in most countries; available over-the-counter in some European and post-Soviet regions.
Role: Neuropeptide complex extracted from cortical brain tissue; enhances cognitive processing and mental performance.
Evidence: In post-COVID cognitive impairment (n=52, open-label observational): improved concentration (p<0.05), executive function control (p<0.05), and auditory-verbal memory (p=0.002) with 10mg intramuscular injection for 20 consecutive days. Evidence is primarily from open-label observational designs rather than rigorous RCTs; most high-quality studies come from post-Soviet regions with limited independent replication.
Dosing: 10mg once daily (intramuscular injection) for 10–20 day treatment courses; may be repeated 3–4 times annually.
Timing: Daily injection during treatment course; typically administered by healthcare provider.
Cost: $40–$120 per month (during active treatment periods)
Availability: Limited availability outside post-Soviet regions; not approved by FDA in the United States.
Role: Anxiolytic and cognition-enhancing peptide; modulates immune and stress response systems.
Evidence: In humans (n=40), combined Selank + phenazepam treatment reduced benzodiazepine side effects (memory impairment, sedation, asthenia) compared to phenazepam monotherapy (n=30) over 4